» Articles » PMID: 9738985

Antitumor Immunity Induction by Intracellular Hyperthermia Using Magnetite Cationic Liposomes

Overview
Specialty Oncology
Date 1998 Sep 17
PMID 9738985
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Induction of antitumor immunity to T-9 rat glioma by intracellular hyperthermia using functional magnetic particles was investigated. Magnetite cationic liposomes (MCLs), which have a positive surface charge, were used as heating mediators for intracellular hyperthermia. Solid T-9 glioma tissues were formed subcutaneously on both femurs of female F344 rats, and MCLs were injected via a needle only into the left solid tumors (treatment side). The rats were then divided into two groups, which received no irradiation, or irradiation for 30 min given three times at 24-h intervals with an alternating magnetic field (118 kHz, 384 Oe). On the treatment side, the tumor tissue disappeared completely in many rats exposed to the magnetic field. The tumor tissue on the opposite side also disappeared completely, even though MCLs were not injected into the right solid tumors. To examine whether a long-lasting and tumor-specific immunity could be generated, the rats that had been cured by the hyperthermia treatment were rechallenged with T-9 cells 3 months later. After a period of transient growth, all tumors disappeared. Furthermore, immunocytochemical assay revealed that the immune response induced by the hyperthermia treatment was mediated by both CD8+ and CD4+ T cells and accompanied by a marked augmentation of tumor-selective cytotoxic T lymphocyte activity. These results suggest that our magnetic particles are potentially effective tools for hyperthermic treatment of solid tumors, because in addition to killing of the tumor cells by heat, a host immune response is induced.

Citing Articles

Magnetic Hyperthermia in Glioblastoma Multiforme Treatment.

Manescu Paltanea V, Antoniac I, Paltanea G, Nemoianu I, Mohan A, Antoniac A Int J Mol Sci. 2024; 25(18).

PMID: 39337552 PMC: 11432100. DOI: 10.3390/ijms251810065.


The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment.

Peng L, Xu Q, Yin S, Zhang Y, Wu H, Liu Y Front Oncol. 2023; 13:1153319.

PMID: 37182180 PMC: 10172578. DOI: 10.3389/fonc.2023.1153319.


Validation of a Temperature-Feedback Controlled Automated Magnetic Hyperthermia Therapy Device.

Sharma A, Jangam A, Low Yung Shen J, Ahmad A, Arepally N, Rodriguez B Cancers (Basel). 2023; 15(2).

PMID: 36672278 PMC: 9856953. DOI: 10.3390/cancers15020327.


Engineering magnetic nano-manipulators for boosting cancer immunotherapy.

Yan B, Wang S, Liu C, Wen N, Li H, Zhang Y J Nanobiotechnology. 2022; 20(1):547.

PMID: 36587223 PMC: 9805281. DOI: 10.1186/s12951-022-01760-8.


Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development.

Wakamatsu K, Ito A, Tamura Y, Hida T, Kamiya T, Torigoe T Cancers (Basel). 2022; 14(22).

PMID: 36428680 PMC: 9688330. DOI: 10.3390/cancers14225588.


References
1.
Kobayashi N, Matsuzaki G, Yoshikai Y, Seki R, Ivanyi J, Nomoto K . V delta 5+ T cells of BALB/c mice recognize the murine heat shock protein 60 target cell specificity. Immunology. 1994; 81(2):240-6. PMC: 1422318. View

2.
Stauffer P, Cetas T, Fletcher A, DeYoung D, Dewhirst M, Oleson J . Observations on the use of ferromagnetic implants for inducing hyperthermia. IEEE Trans Biomed Eng. 1984; 31(1):76-90. DOI: 10.1109/TBME.1984.325373. View

3.
Aruga A, Aruga E, Chang A . Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant. Cancer Res. 1997; 57(15):3230-7. View

4.
Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R . Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia. 1993; 9(1):51-68. DOI: 10.3109/02656739309061478. View

5.
Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T . Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn J Cancer Res. 1997; 88(7):630-2. PMC: 5921484. DOI: 10.1111/j.1349-7006.1997.tb00429.x. View